Rani Therapeutics Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Rani Therapeutics Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Rani Therapeutics Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $5.43M, a 466% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $5.43M +$4.47M +466% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $5.75M +$4.56M +382% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $5.97M +$4.55M +320% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $718K -$347K -32.6% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $959K -$343K -26.3% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $1.19M +$195K +19.5% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $1.42M +$264K +22.8% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $1.07M +$1.07M Dec 31, 2022 10-K 2024-03-20
Q3 2022 $1.3M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $999K Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.16M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.